Oppenheimer & Co. Inc. lifted its position in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 10.9% during the third quarter, Holdings Channel.com reports. The firm owned 57,248 shares of the company’s stock after purchasing an additional 5,618 shares during the period. Oppenheimer & Co. Inc.’s holdings in BlackRock Capital Allocation Term Trust were worth $942,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of BCAT. Prevail Innovative Wealth Advisors LLC bought a new position in shares of BlackRock Capital Allocation Term Trust in the second quarter valued at $1,452,000. Almitas Capital LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter worth about $728,000. Quarry LP lifted its position in BlackRock Capital Allocation Term Trust by 68.4% in the 2nd quarter. Quarry LP now owns 69,034 shares of the company’s stock valued at $1,133,000 after acquiring an additional 28,045 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in BlackRock Capital Allocation Term Trust by 4.3% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 133,238 shares of the company’s stock valued at $2,186,000 after purchasing an additional 5,438 shares during the last quarter. Finally, Sanctuary Advisors LLC acquired a new position in BlackRock Capital Allocation Term Trust during the 2nd quarter valued at about $2,967,000. 36.12% of the stock is currently owned by institutional investors.
BlackRock Capital Allocation Term Trust Price Performance
Shares of BlackRock Capital Allocation Term Trust stock opened at $16.01 on Wednesday. BlackRock Capital Allocation Term Trust has a 52 week low of $14.60 and a 52 week high of $17.18. The business has a 50 day moving average price of $16.27 and a 200-day moving average price of $16.32.
BlackRock Capital Allocation Term Trust Increases Dividend
Insider Buying and Selling at BlackRock Capital Allocation Term Trust
In other BlackRock Capital Allocation Term Trust news, major shareholder Saba Capital Management, L.P. sold 14,973 shares of the stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $16.41, for a total value of $245,706.93. Following the completion of the sale, the insider now owns 16,302,733 shares in the company, valued at approximately $267,527,848.53. This trade represents a 0.09 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last three months, insiders have sold 723,927 shares of company stock worth $11,925,047.
BlackRock Capital Allocation Term Trust Company Profile
–
See Also
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- Earnings Per Share Calculator: How to Calculate EPS
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Breakout Stocks: What They Are and How to Identify Them
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.